SAN DIEGO (AP) — SAN DIEGO (AP) — Gossamer Bio Inc. (GOSS) on Friday reported a loss of $46.7 million in its first quarter.
The San Diego-based company said it had a loss of 20 cents per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The biopharmaceutical company posted revenue of $17 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GOSS at https://www.zacks.com/ap/GOSS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
